PHS
LIVN icon

PFM Health Sciences’s LivaNova LIVN Stock Holding History

PFM Health Sciences’s Portfolio LIVN Stock Details LIVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-244,851
Closed -$12.3M – 96
2016
Q2 		$12.3M Buy
+244,851
New +$12.4M 0.37% 67

Other funds holding LIVN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HIP
Hengistbury Investment Partners London, United Kingdom $240M AUM 17.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PFM Health Sciences's LIVN Position: Q3 2016 in Review

PFM Health Sciences sold out of LivaNova (LIVN) in Q3 2016, closing a stake of 244,851 shares — an estimated $12.3M sold.

PFM Health Sciences first reported a position in LIVN in Q2 2016 and held it in 1 quarter. The position peaked at $12.3M in Q2 2016. 166 funds tracked by Wall St. Rank hold LIVN as of Q3 2016.

  • PFM Health Sciences reported no remaining LivaNova position as of Q3 2016 after selling out during the quarter.
  • PFM Health Sciences sold 244,851 LivaNova shares in Q3 2016, an estimated $12.3M.
  • PFM Health Sciences first reported a position in LivaNova in Q2 2016 and held it in 1 quarter.
  • PFM Health Sciences's LivaNova position peaked at $12.3M in Q2 2016.
  • 166 funds tracked by Wall St. Rank held LivaNova as of Q3 2016.

Based on PFM Health Sciences's 13F filing for Q3 2016, filed 14 Nov 2016.